Literature DB >> 7808850

The Histoplasma capsulatum antigen assay in disseminated histoplasmosis in children.

M F Fojtasek1, M B Kleiman, P Connolly-Stringfield, R Blair, L J Wheat.   

Abstract

Progressive disseminated histoplasmosis is often fatal without treatment and requires rapid and accurate laboratory diagnosis. Radioimmunoassay for Histoplasma capsulatum var. capsulatum antigen has been established as a sensitive and accurate diagnostic technique for disseminated histoplasmosis in adults; this study examines the radioimmunoassay in children. The clinical and laboratory records of 26 patients 18 years old or younger in whom H. capsulatum antigen was detected in urine by radioimmunoassay and at least one other positive corroborative standard test were evaluated. Twenty-two (85%) had disseminated disease, and 4 (15%) had self-limited pulmonary disease. Positive corroborative tests included serologic tests in 17 of 22 (77%) patients tested, tissue stains in 5 of 9 (56%) and fungal cultures in 16 of 24 (67%). Patients with disseminated histoplasmosis had a greater degree of antigenuria than those with self-limited infection. In 20 patients with progressive disease treated with amphotericin B, antigen levels declined, and the decrease in antigenuria correlated with clinical improvement. The radioimmunoassay for H. capsulatum antigen in urine is an important test in the diagnosis of disseminated histoplasmosis and is useful for assessing the efficacy of treatment. The presence of urinary antigen is strong evidence for progressive disease that requires treatment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7808850     DOI: 10.1097/00006454-199409000-00010

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  7 in total

1.  Development of a novel antigen detection test for histoplasmosis.

Authors:  B L Gomez; J I Figueroa; A J Hamilton; B L Ortiz; M A Robledo; A Restrepo; R J Hay
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

2.  DIAGNOSIS OF HISTOPLASMOSIS.

Authors:  Allan Jefferson Guimarães; Joshua D Nosanchuk; Rosely Maria Zancopé-Oliveira
Journal:  Braz J Microbiol       Date:  2006-01       Impact factor: 2.476

3.  Molecular detection of Histoplasma capsulatum var. capsulatum in human clinical samples.

Authors:  Andrea Bracca; María Elena Tosello; Javier E Girardini; Susana L Amigot; Carlos Gomez; Esteban Serra
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

4.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

5.  Progressive disseminated histoplasmosis in children living with HIV: a case series study.

Authors:  Miguel García-Boyano; Greta Miño-León; William Vega; Luis Prieto; Nelly Chávez-Solórzano; Dalton Solís Montiel
Journal:  Eur J Pediatr       Date:  2021-02-08       Impact factor: 3.183

6.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04

7.  Antibody therapy for histoplasmosis.

Authors:  Joshua D Nosanchuk; Rosely M Zancopé-Oliveira; Andrew J Hamilton; Allan J Guimarães
Journal:  Front Microbiol       Date:  2012-02-02       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.